MedTrace Logo

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

NCT06134011 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2023-11-18

No results posted yet for this study

Summary

In the study, the investigators obtained gastric cancer tissues from 480 gastric cancer patients who had undergone surgery at the Zhejiang Cancer Hospital's biospecimen bank between 2012-2019, and obtained relevant clinical information. The gastric cancer tissues were subjected to transcriptomic, metabolomic and other multi-omics testing, and analyzed for the metabolic changes of gastric cancer, and proposed to discover relevant therapeutic targets.

Conditions

Interventions

OTHER

Without any intervention

There were no special interventions for the two groups.

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-10
Primary Completion
2024-09-10
Completion
2024-09-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06134011 on ClinicalTrials.gov